New Research Presented to ICU Specialists

At ESICM 2025 in Munich, Anna Wijen of Maastricht UMC+ presented new research focused on accelerating sepsis diagnostics through culture-free bacterial detection in whole blood.

The presentation was delivered to an audience of ICU specialists working directly with critically ill patients affected by sepsis.

As a PhD candidate at Maastricht UMC+, Wijen is involved in advancing molecular approaches to bloodstream infection diagnostics.

Addressing the Challenges of Sepsis Detection

The presentation focused on one of the major challenges in critical care microbiology: how to identify bacterial infections faster than conventional blood culture workflows allow.

During the session, clinicians raised practical questions about how molecular diagnostics should be interpreted in real-world care settings.

• How can clinicians distinguish true infection from contamination?
• What happens when molecular tests detect bacteria but blood cultures remain negative?

Combining Molecular Data With Clinical Interpretation

According to the presentation, Molecular Culture ID® supports clinical interpretation by combining molecular findings with the broader clinical picture.

This approach may help reveal infections that conventional culture methods fail to detect, particularly in situations where rapid intervention is critical.

Moving Sepsis Diagnostics Forward

Sepsis remains one of the most time-sensitive conditions in intensive care medicine, where delays in pathogen identification can directly affect treatment decisions and patient outcomes.

The presentation highlighted the growing interest in molecular diagnostics as hospitals continue evaluating faster and more workflow-compatible approaches to infectious disease testing.